4-Hexylresorcinol - CAS 136-77-6
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
4-Hexylresorcinol
Catalog Number:
136-77-6
Synonyms:
1-(2',4'-Dihydroxyphenyl)hexane;1-(2,4-Dihydroxyphenyl)hexane;1,3-Benzenediol, 4-hexyl-;1,3-Benzenediol,4-Hexyl-1,3-benzenediol;1,3-Dihydroxy-4-Hexylbenzene;1,3-Dihydroxy-4-n-hexylbenzene
CAS Number:
136-77-6
Description:
4-Hexylresorcinol, a phenol derivative, could be commonly used as antioxidant, vermifuge and food additives.
Molecular Weight:
194.27
Molecular Formula:
C12H18O2
Quantity:
Grams-Kilos
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CCCCCCC1=C(C=C(C=C1)O)O
InChI:
InChI=1S/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3
InChIKey:
WFJIVOKAWHGMBH-UHFFFAOYSA-N
Targets:
Others
Chemical Structure
CAS 136-77-6 4-Hexylresorcinol

Related Products


CAS 3759-92-0 Furaltadone Hydrochloride

Furaltadone Hydrochloride
(CAS: 3759-92-0)

Furaltadone HCl is an antibacterial and has distinct curative effect in the treatment of coccidiosis.

DPY-6602
(CAS: 145696-60-2)

DPY-6602, a pyrrole derivative, could be widely used as an intermediate in sorts of areas like photosensitizers and antitumor drugs.

CAS 109581-93-3 Tacrolimus monohydrate

Tacrolimus monohydrate
(CAS: 109581-93-3)

Tacrolimus monohydrate is a potent immunosuppressive drug often administered to transplant recipient patients and exhibits a variety of adverse cardiovascular e...

CAS 1164470-53-4 Sal003

Sal003
(CAS: 1164470-53-4)

Sal003 increases eIF2α phosphorylation status by blocking eIF2a phosphatases in cells.

CAS 4547-24-4 Corosolic acid

Corosolic acid
(CAS: 4547-24-4)

Corosolic acid, that is isolated from the barks of Lagerstroemia speciosa, contains anti-angiogenic activity that can suppress FAK signaling induced by angiopoi...

CAS 1046045-61-7 FGH10019

FGH10019
(CAS: 1046045-61-7)

FGH10019 is a novel sterol regulatory element-binding protein (SREBP) inhibitor with IC50 of 1 μM, 5-10 times lower than the IC50 of fatostatin (~10 μM).

CAS 170787-99-2 Efaproxiral Sodium

Efaproxiral Sodium
(CAS: 170787-99-2)

Efaproxiral, a synthetic allosteric modifier of hemoglobinoxygen binding affinity, has been shown to bind reversibly to hemoglobin, stabilizing the deoxyhemoglobi...

CAS 56180-94-0 Acarbose

Acarbose
(CAS: 56180-94-0)

Acarbose is an inhibitor of intestinal alpha-glucosidase, used to treat type 2 diabetes mellitus.

Navamepent
(CAS: 1251537-11-7)

Navamepent is an inflammation mediator inhibitor and lipid modulator originated by Resolvyx Pharmaceuticals and licensed to Auven Therapeutics in 2011. Treatmen...

CAS 288-32-4 Imidazole

Imidazole
(CAS: 288-32-4)

Imidazole, a highly polar compound, has been used extensively as a corrosion inhibitor and a buffer in the pH range of 6.2-7.8.

CK-2289
(CAS: 101183-99-7)

CK-2289 is an type III cyclic 3'5'-adenosine monophosphate phosphodiesterase inhibitor. It may be used in the treatment of congestive heart failure.

LY 181984
(CAS: 3955-50-8)

LY 181984 is an antitumor sulfonylurea.

CAS 3902-71-4 Trioxsalen

Trioxsalen
(CAS: 3902-71-4)

A derivative of psoralen, which intercalates into DNA and forms DNA single-strand adducts and interstrand crosslinks.

(S)-3-aminotetrahydrothiophene 1,1-dioxi
(CAS: 935455-28-0)

(S)-3-aminotetrahydrothiophene 1,1-dioxide hydrochloride is an important sulfur-containing heterocyclic compounds. It is widely used as building blocks in many ...

CAS 97792-45-5 Lappaconite HBr

Lappaconite HBr
(CAS: 97792-45-5)

Lappaconite Hydrobromide is a kind of alkaloid extracted from Aconitum sinomontanum Nakai and has anti-inflammatory effects.

CVT-2759
(CAS: 342419-10-7)

CVT-2759 is a potential partial agonist of A(1)-ADORs, may be used to slow AV nodal conduction.

AT 1902
(CAS: 80155-82-4)

AT 1902 is a bio-active compound, but no detailed information has been published yet.

CAS 1217809-61-4 Ivabradine-d3 Hydrochloride

Ivabradine-d3 Hydrochloride
(CAS: 1217809-61-4)

The hydrochloride salt form of isotope labelled Ivabradine which is an inhibitor of If current of the sinoatrial node and could used in the treatment of Chronic...

CAS 68278-23-9 Eflornithine hydrochloride

Eflornithine hydrochloride
(CAS: 68278-23-9)

Eflornithine hydrochloride is a drug found to be effective in the treatment of facial hirsutism. It is a "suicide inhibitor," irreversibly binding to Ornithine ...

CAS 144-80-9 Sulfacetamide

Sulfacetamide
(CAS: 144-80-9)

Sulfacetamide is a sulfonamide antibiotic as a dihydropteroate Synthase inhibitor. It is a competitive inhibitor of bacterial para-aminobenzoic acid, which is r...

Reference Reading


1.Development and validation of an analytical method for the determination of 4-hexylresorcinol in food.
Kim YH1, Kim JM1, Lee JS1, Gang SR2, Lim HS3, Kim M3, Lee OH4. Food Chem. 2016 Jan 1;190:1086-92. doi: 10.1016/j.foodchem.2015.06.051. Epub 2015 Jun 19.
This study presents a method validation for extraction and quantitative analysis of 4-hexylresorcinol residues in shrimp and crab meat using HPLC-FLD. We were focused on the collaboratively analysis of each shrimp and crab meat samples, and developed LC-MS/MS method for the correct confirmation of the identity of compound. Validation parameters; selectivity, linearity, LOD, LOQ, accuracy, precision, and measurement of uncertainty were attained. The measurement of uncertainty was based on the precision study, data related to the performance of the analytical process and quantification of 4-hexylresorcinol. For HPLC-FLD analysis, the recoveries of 4-hexylresorcinol from spiked samples at levels of 0.2-10.0 ppm ranged from 92.54% to 97.67% with RSDs between 0.07% and 1.88%. According to these results, the method has been proven to be appropriate for extraction and determination of 4-hexylresorcinol, and can be used to maintain the safety of shrimp and crab products containing 4-hexylresorcinol residues.
2.Tyrosinase-Catalyzed Hydroxylation of 4-Hexylresorcinol, an Antibrowning and Depigmenting Agent: A Kinetic Study.
Ortiz-Ruiz CV1, Berna J1, Rodriguez-Lopez JN1, Tomas V1, Garcia-Canovas F1. J Agric Food Chem. 2015 Aug 12;63(31):7032-40. doi: 10.1021/acs.jafc.5b02523. Epub 2015 Jul 29.
4-Hexylresorcinol (HR) is a compound used in the food and cosmetic industries as an antibrowning and lightening agent. Its use is mainly attributed to its inhibitory effect on the enzyme tyrosinase. However, the enzyme hydroxylates HR to an o-diphenol, which it then oxidizes to an o-quinone, which rapidly isomerizes to p-quinone. For tyrosinase to act in this way, the Eox form (oxy-tyrosinase) must be present in the reaction medium, which can be brought about by (a) hydrogen peroxide, (b) ascorbic acid, or (c) catalytic concentrations of o-diphenol and a reductant (NADH) to maintain it constant. This work demonstrates that HR is a substrate of tyrosinase and proposes a mechanism for its action. Its kinetic characterization provides a catalytic constant of 0.85 ± 0.04 s(-1) and a Michaelis constant of 60.31 ± 6.73 μM.
3.Silk fibroin and 4-hexylresorcinol incorporation membrane for guided bone regeneration.
Lee SW1, Kim SG, Song JY, Kweon H, Jo YY, Lee KG, Kang SW, Yang BE. J Craniofac Surg. 2013 Nov;24(6):1927-30. doi: 10.1097/SCS.0b013e3182a3050c.
The objective of this study was to demonstrate that a silk fibroin (SF) and 4-hexylresorcinol (4-HR) incorporation membrane could be used for a guided bone regeneration technique. Fourier transform infrared measurements were obtained to determine change of physical property of SF membrane by 4-HR incorporation. Two peri-implant defects, 3.0 × 5.0 mm (width × length), were prepared on the lateral side of the implant hole in the tibia of New Zealand white rabbits (n = 8). The peri-implant defect was left unfilled in the control group. Silk fibroin + 4-HR membrane was applied to the peri-implant defect in the experimental group. The 8 animals were killed at 8 weeks after implantation. Subsequently, removal torque test and histomorphometric evaluation were done. Fourier transform infrared spectroscopy showed no specific chemical interaction between 4-HR and SF. In the histomorphometric analysis, the mean bone regeneration was 18.3 ± 1.9 mm(2) in the experimental group and 9.
4.Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010).
Wentworth AB1, Yiannias JA2, Keeling JH3, Hall MR3, Camilleri MJ4, Drage LA5, Torgerson RR5, Fett DD6, Prakash AV7, Scalf LA8, Allen EM5, Johnson JS2, Singh N2, Nordberg Linehan DL3, Killian JM9, Davis MD10. J Am Acad Dermatol. 2014 Feb;70(2):269-75.e4. doi: 10.1016/j.jaad.2013.09.047. Epub 2013 Nov 20.
BACKGROUND: Patch testing is essential for identification of culprits causing allergic contact dermatitis.